Coexpression cluster:C2
From FANTOM5_SSTAR
Full id: C2_Eosinophils_Neutrophils_CD14_Whole_Basophils_Peripheral_Mast
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
0.000970340307810119 | 0.0093064456794516 | 4 | 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate (KEGG):00532 |
4.65243803465159e-05 | 0.000718291042910843 | 17 | 268 | MAPK signaling pathway (KEGG):04010 |
0.0012974158667898 | 0.0117323463382564 | 14 | 265 | Cytokine-cytokine receptor interaction (KEGG):04060 |
1.54556235118358e-08 | 9.78340968299204e-07 | 19 | 189 | Chemokine signaling pathway (KEGG):04062 |
7.05806799987445e-05 | 0.000971251531287072 | 9 | 86 | Apoptosis (KEGG):04210 |
0.00560489145848038 | 0.0385640901436748 | 8 | 130 | Axon guidance (KEGG):04360 |
9.53279137564679e-09 | 7.54282117598052e-07 | 16 | 128 | Osteoclast differentiation (KEGG):04380 |
0.00297793893602976 | 0.0227112692350222 | 6 | 69 | Complement and coagulation cascades (KEGG):04610 |
0.00124408104351538 | 0.0114130913122498 | 8 | 102 | Toll-like receptor signaling pathway (KEGG):04620 |
3.23218703486014e-07 | 1.13665244059248e-05 | 10 | 59 | NOD-like receptor signaling pathway (KEGG):04621 |
2.16010784423818e-07 | 8.0432250906045e-06 | 11 | 71 | RIG-I-like receptor signaling pathway (KEGG):04622 |
0.00056399576137951 | 0.00575821478956822 | 10 | 137 | Natural killer cell mediated cytotoxicity (KEGG):04650 |
2.41260800961241e-06 | 6.36325362535272e-05 | 12 | 108 | T cell receptor signaling pathway (KEGG):04660 |
3.17485654046503e-06 | 8.03873676045745e-05 | 10 | 75 | B cell receptor signaling pathway (KEGG):04662 |
5.12612718515944e-06 | 0.000111890983041584 | 10 | 79 | Fc epsilon RI signaling pathway (KEGG):04664 |
2.67933247547575e-05 | 0.000472945725325111 | 10 | 95 | Fc gamma R-mediated phagocytosis (KEGG):04666 |
0.000722949550586345 | 0.00715042289876807 | 9 | 117 | Leukocyte transendothelial migration (KEGG):04670 |
2.34935311162699e-06 | 6.36325362535272e-05 | 13 | 127 | Neurotrophin signaling pathway (KEGG):04722 |
0.00493451687970843 | 0.0349360353873404 | 7 | 101 | GnRH signaling pathway (KEGG):04912 |
0.00297793893602976 | 0.0227112692350222 | 6 | 69 | Adipocytokine signaling pathway (KEGG):04920 |
0.000751793538402944 | 0.00732131245860098 | 6 | 53 | Amyotrophic lateral sclerosis (ALS) (KEGG):05014 |
7.70966769921315e-05 | 0.00103457480411096 | 8 | 68 | Epithelial cell signaling in Helicobacter pylori infection (KEGG):05120 |
4.82141295271982e-06 | 0.000108998371395416 | 9 | 62 | Shigellosis (KEGG):05131 |
3.05774469648286e-08 | 1.75959308443059e-06 | 12 | 73 | Leishmaniasis (KEGG):05140 |
5.86750511288341e-05 | 0.000844120621921636 | 10 | 104 | Chagas disease (American trypanosomiasis) (KEGG):05142 |
0.000610564574659582 | 0.00613472025015104 | 6 | 51 | Malaria (KEGG):05144 |
0.000101033887833748 | 0.00127908901997525 | 11 | 133 | Toxoplasmosis (KEGG):05145 |
0.00586709168027053 | 0.0399340756302284 | 5 | 56 | Staphylococcus aureus infection (KEGG):05150 |
1.37107190052063e-09 | 1.44648085504927e-07 | 20 | 182 | Tuberculosis (KEGG):05152 |
0.00187990545709692 | 0.0163010980046897 | 9 | 134 | Measles (KEGG):05162 |
7.84511699799779e-05 | 0.00103457480411096 | 13 | 176 | Influenza A (KEGG):05164 |
0.00135386157892107 | 0.0120703433726344 | 16 | 327 | Pathways in cancer (KEGG):05200 |
0.00394772178271287 | 0.0287230791776695 | 6 | 73 | Chronic myeloid leukemia (KEGG):05220 |
0.00294173554509008 | 0.0227112692350222 | 7 | 92 | Rheumatoid arthritis (KEGG):05323 |
1.59686223955026e-07 | 7.22009855453797e-06 | 11 | 69 | IL-5 Signaling Pathway (Wikipathways):WP127 |
0.0028095001695359 | 0.0225282609957947 | 8 | 116 | Androgen Receptor Signaling Pathway (Wikipathways):WP138 |
3.47523886287376e-08 | 1.83318850016591e-06 | 16 | 140 | Regulation of toll-like receptor signaling pathway (Wikipathways):WP1449 |
4.38535543828732e-05 | 0.000693982498108968 | 9 | 81 | Apoptosis Modulation and Signaling (Wikipathways):WP1772 |
0.00166512315533981 | 0.0146392077406958 | 3 | 12 | IL-1 Signaling Pathway (Wikipathways):WP195 |
0.00204013856806717 | 0.017218769514487 | 5 | 44 | IL-7 Signaling Pathway (Wikipathways):WP205 |
1.52141726275597e-10 | 1.92611425464906e-08 | 20 | 161 | B Cell Receptor Signaling Pathway (Wikipathways):WP23 |
4.05992976265879e-07 | 1.35259765250685e-05 | 17 | 188 | TNF-alpha/NF-kB Signaling Pathway (Wikipathways):WP231 |
8.24393176446049e-07 | 2.48495657471595e-05 | 14 | 135 | Adipogenesis (Wikipathways):WP236 |
6.43535237978491e-05 | 0.000905239568089744 | 9 | 85 | Apoptosis (Wikipathways):WP254 |
4.96725732573373e-05 | 0.000748636639807012 | 10 | 102 | IL-3 Signaling Pathway (Wikipathways):WP286 |
0.00496720882284461 | 0.0349360353873404 | 9 | 155 | Myometrial Relaxation and Contraction Pathways (Wikipathways):WP289 |
0.00297793893602976 | 0.0227112692350222 | 6 | 69 | Kit Receptor Signaling Pathway (Wikipathways):WP304 |
0.00117672405999836 | 0.0109539166173377 | 5 | 39 | FAS pathway and Stress induction of HSP regulation (Wikipathways):WP314 |
3.83850065111146e-05 | 0.000656694841122583 | 10 | 99 | IL-6 Signaling Pathway (Wikipathways):WP364 |
7.18490455338091e-06 | 0.000142126393196566 | 14 | 162 | MAPK signaling pathway (Wikipathways):WP382 |
0.00506296573549221 | 0.0352182122040282 | 4 | 34 | p38 MAPK Signaling Pathway (Wikipathways):WP400 |
0.00281158391574689 | 0.0225282609957947 | 4 | 29 | MAPK Cascade (Wikipathways):WP422 |
2.01207644187443e-07 | 7.9602774231657e-06 | 17 | 179 | EGFR1 Signaling Pathway (Wikipathways):WP437 |
0.00306696130254474 | 0.0231117441013193 | 13 | 260 | GPCRs, Class A Rhodopsin-like (Wikipathways):WP455 |
7.18490455338091e-06 | 0.000142126393196566 | 14 | 162 | Insulin Signaling (Wikipathways):WP481 |
5.04216976617355e-07 | 1.59584673099393e-05 | 11 | 77 | IL-2 Signaling Pathway (Wikipathways):WP49 |
0.0038389684395675 | 0.0282565932819328 | 9 | 149 | Calcium Regulation in the Cardiac Cell (Wikipathways):WP536 |
4.18748060656859e-05 | 0.000693982498108968 | 10 | 100 | Senescence and Autophagy (Wikipathways):WP615 |
3.74521509285015e-11 | 5.92680288443537e-09 | 19 | 133 | T Cell Receptor Signaling Pathway (Wikipathways):WP69 |
0.00454012897115326 | 0.0326579731675002 | 4 | 33 | Serotonin HTR1 Group and FOS Pathway (Wikipathways):WP722 |
0.000262964690315585 | 0.00286994222361665 | 9 | 102 | Toll-like receptor signaling pathway (Wikipathways):WP75 |
3.10611034979892e-16 | 1.96616785142271e-13 | 45 | 511 | Signaling in Immune system (Reactome):REACT_6900 |
1.75767438366783e-07 | 7.41738589907823e-06 | 19 | 220 | Signalling by NGF (Reactome):REACT_11061 |
3.66610659740041e-09 | 3.3152078230778e-07 | 32 | 466 | Hemostasis (Reactome):REACT_604 |
0.00734271248841417 | 0.0489256526859597 | 13 | 289 | Metabolism of lipids and lipoproteins (Reactome):REACT_22258 |
0.00197047930519973 | 0.0168555864890734 | 33 | 932 | Signaling by GPCR (Reactome):REACT_14797 |
0.00351131175466853 | 0.0261489451847668 | 9 | 147 | Apoptosis (Reactome):REACT_578 |
7.94824055889127e-06 | 0.000152461705266005 | 12 | 121 | Signaling by Rho GTPases (Reactome):REACT_11044 |
0.000346352469068364 | 0.00371595106644533 | 6 | 46 | Interactions of the immunoglobulin superfamily (IgSF) member proteins (Reactome):REACT_23853 |
6.59401064705715e-08 | 3.2107759535286e-06 | 42 | 816 | TGF beta receptor up reg. targets (Netpath):NetPath_7 |
0.000382646869233026 | 0.00403692447040842 | 30 | 740 | TGF beta receptor down reg. targets (Netpath):NetPath_7 |
3.85687004363391e-06 | 9.04221754674173e-05 | 35 | 728 | TNF alpha/NF-kB up reg. targets (Netpath):NetPath_9 |
0.000142565457657669 | 0.00173546028264047 | 12 | 162 | TNF alpha/NF-kB down reg. targets (Netpath):NetPath_9 |
0.0065913605218177 | 0.0443865022373469 | 9 | 162 | AR down reg. targets (Netpath):NetPath_2 |
0.000197233912307263 | 0.00222944761590174 | 15 | 246 | B Cell Receptor up reg. targets (Netpath):NetPath_12 |
2.68973872222812e-05 | 0.000472945725325111 | 14 | 182 | B Cell Receptor down reg. targets (Netpath):NetPath_12 |
0.00276619478071525 | 0.0225282609957947 | 6 | 68 | T Cell Receptor down reg. targets (Netpath):NetPath_11 |
9.36954883482032e-05 | 0.00121039273723291 | 12 | 155 | IL-1 up reg. targets (Netpath):NetPath_13 |
3.66152701679595e-13 | 7.72582200543945e-11 | 37 | 433 | IL-2 up reg. targets (Netpath):NetPath_14 |
1.380321598015e-08 | 9.70826190603881e-07 | 24 | 295 | IL-2 down reg. targets (Netpath):NetPath_14 |
0.00015754639755304 | 0.00188163905002027 | 6 | 40 | IL-3 up reg. targets (Netpath):NetPath_15 |
0.000178526829517874 | 0.00205468151063299 | 14 | 217 | IL-4 up reg. targets (Netpath):NetPath_16 |
1.66271212006162e-05 | 0.000309557874117355 | 10 | 90 | IL-4 down reg. targets (Netpath):NetPath_16 |
3.51478877303396e-14 | 1.11243064666525e-11 | 22 | 131 | IL-5 up reg. targets (Netpath):NetPath_17 |
5.75159782697013e-06 | 0.00012135871414907 | 10 | 80 | IL-6 up reg. targets (Netpath):NetPath_18 |
0.000164491806646958 | 0.00192820951125045 | 7 | 57 | IL-7 up reg. targets (Netpath):NetPath_19 |
0.00267179014727005 | 0.0222531995160782 | 3 | 14 | IL-7 down reg. targets (Netpath):NetPath_19 |
0.000241983421003513 | 0.00268728957009164 | 5 | 28 | {C5,29} (Static Module):NA |
0.00117672405999836 | 0.0109539166173377 | 5 | 39 | {CASP3,41} (Static Module):NA |
4.28872827565316e-05 | 0.000693982498108968 | 22 | 406 | {GRB2,414} (Static Module):NA |
5.64386248953368e-05 | 0.000830829059505772 | 5 | 21 | {HRAS,27} (Static Module):NA |
9.22054542637176e-07 | 2.65300238858788e-05 | 13 | 117 | {MAPK14,123} (Static Module):NA |
0.000536858715792336 | 0.00557100929666473 | 5 | 33 | {NFKB1,33} (Static Module):NA |
3.62352483161167e-06 | 8.82188930157764e-05 | 13 | 132 | {RAC1,133} (Static Module):NA |
0.00013081130018214 | 0.00162359907873127 | 7 | 55 | {TRAF6,55} (Static Module):NA |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0005515 | protein binding | 2.74509374464167e-32 |
GO:0007243 | protein kinase cascade | 2.39783232829899e-28 |
GO:0009611 | response to wounding | 5.51958463244479e-26 |
GO:0006952 | defense response | 5.51958463244479e-26 |
GO:0009605 | response to external stimulus | 5.51958463244479e-26 |
GO:0006915 | apoptosis | 1.17843262725126e-22 |
GO:0012501 | programmed cell death | 2.11084753531072e-22 |
GO:0007242 | intracellular signaling cascade | 5.27788377827644e-22 |
GO:0008219 | cell death | 8.20352805547855e-22 |
GO:0016265 | death | 8.20352805547855e-22 |
GO:0007165 | signal transduction | 4.30487153438062e-20 |
GO:0006950 | response to stress | 1.380317756955e-19 |
GO:0048519 | negative regulation of biological process | 8.19828682175533e-19 |
GO:0007154 | cell communication | 7.3823854543091e-18 |
GO:0044464 | cell part | 1.85889022129786e-17 |
GO:0048523 | negative regulation of cellular process | 3.05233528151365e-17 |
GO:0005737 | cytoplasm | 2.27341334624827e-15 |
GO:0048468 | cell development | 2.27341334624827e-15 |
GO:0065007 | biological regulation | 2.27341334624827e-15 |
GO:0044424 | intracellular part | 3.22784694763059e-15 |
GO:0006954 | inflammatory response | 8.51939799247491e-15 |
GO:0042981 | regulation of apoptosis | 4.00924270229385e-14 |
GO:0043067 | regulation of programmed cell death | 6.96819389499938e-14 |
GO:0050789 | regulation of biological process | 4.88089431682367e-13 |
GO:0005622 | intracellular | 6.98197252593015e-13 |
GO:0065009 | regulation of a molecular function | 1.34127106441045e-12 |
GO:0002376 | immune system process | 2.85711686506574e-12 |
GO:0048518 | positive regulation of biological process | 4.65452164150995e-12 |
GO:0048869 | cellular developmental process | 7.53085136080446e-12 |
GO:0030154 | cell differentiation | 7.53085136080446e-12 |
GO:0032502 | developmental process | 1.42944481668252e-11 |
GO:0043227 | membrane-bound organelle | 6.62026845184887e-11 |
GO:0043231 | intracellular membrane-bound organelle | 1.30194602817798e-10 |
GO:0006955 | immune response | 3.39802702451023e-10 |
GO:0004674 | protein serine/threonine kinase activity | 8.69936814223141e-10 |
GO:0016043 | cellular component organization and biogenesis | 1.73376669626815e-09 |
GO:0050794 | regulation of cellular process | 1.82680086375628e-09 |
GO:0001816 | cytokine production | 7.49599132013846e-09 |
GO:0045087 | innate immune response | 8.2988231132907e-09 |
GO:0043226 | organelle | 8.90891577650755e-09 |
GO:0043066 | negative regulation of apoptosis | 1.1348732510678e-08 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.14571224699502e-08 |
GO:0043069 | negative regulation of programmed cell death | 1.36712346560301e-08 |
GO:0043229 | intracellular organelle | 1.44804535625172e-08 |
GO:0042221 | response to chemical stimulus | 3.17902881772514e-08 |
GO:0006464 | protein modification process | 3.56527372285036e-08 |
GO:0048522 | positive regulation of cellular process | 3.56527372285036e-08 |
GO:0043687 | post-translational protein modification | 3.59860419209216e-08 |
GO:0030036 | actin cytoskeleton organization and biogenesis | 4.21987174972899e-08 |
GO:0002250 | adaptive immune response | 5.25485933906375e-08 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 5.25485933906375e-08 |
GO:0045321 | leukocyte activation | 7.13617488655799e-08 |
GO:0030029 | actin filament-based process | 9.51583661415444e-08 |
GO:0001775 | cell activation | 1.00470138746343e-07 |
GO:0000074 | regulation of progression through cell cycle | 1.22075889019874e-07 |
GO:0006512 | ubiquitin cycle | 1.53729399747906e-07 |
GO:0051726 | regulation of cell cycle | 2.00933992315588e-07 |
GO:0008047 | enzyme activator activity | 2.22024391949892e-07 |
GO:0030695 | GTPase regulator activity | 2.56329182083249e-07 |
GO:0043412 | biopolymer modification | 2.81440393036738e-07 |
GO:0048856 | anatomical structure development | 2.81440393036738e-07 |
GO:0045786 | negative regulation of progression through cell cycle | 2.81440393036738e-07 |
GO:0005634 | nucleus | 3.02101488965551e-07 |
GO:0009607 | response to biotic stimulus | 4.77729790936277e-07 |
GO:0065008 | regulation of biological quality | 6.79608815123395e-07 |
GO:0009966 | regulation of signal transduction | 7.72012816372328e-07 |
GO:0050776 | regulation of immune response | 7.83195376909534e-07 |
GO:0002682 | regulation of immune system process | 9.71854813245851e-07 |
GO:0016020 | membrane | 1.43394114318094e-06 |
GO:0002467 | germinal center formation | 1.54806276020501e-06 |
GO:0005886 | plasma membrane | 2.36025001158794e-06 |
GO:0019538 | protein metabolic process | 2.78360310437701e-06 |
GO:0050790 | regulation of catalytic activity | 2.93575361530114e-06 |
GO:0008134 | transcription factor binding | 3.44332806529627e-06 |
GO:0008104 | protein localization | 3.72323964797527e-06 |
GO:0008283 | cell proliferation | 9.51630512223467e-06 |
GO:0048731 | system development | 9.71205435558929e-06 |
GO:0044260 | cellular macromolecule metabolic process | 1.25379744376044e-05 |
GO:0051240 | positive regulation of multicellular organismal process | 1.28994795855984e-05 |
GO:0051707 | response to other organism | 1.31834484433513e-05 |
GO:0042226 | interleukin-6 biosynthetic process | 1.40637468618215e-05 |
GO:0050778 | positive regulation of immune response | 1.40637468618215e-05 |
GO:0051246 | regulation of protein metabolic process | 1.42290576868954e-05 |
GO:0002684 | positive regulation of immune system process | 1.53342023952661e-05 |
GO:0045184 | establishment of protein localization | 1.54201292486783e-05 |
GO:0051704 | multi-organism process | 1.64486562329149e-05 |
GO:0009893 | positive regulation of metabolic process | 1.65703289280465e-05 |
GO:0033036 | macromolecule localization | 1.8297649351406e-05 |
GO:0016064 | immunoglobulin mediated immune response | 1.93857933250456e-05 |
GO:0043170 | macromolecule metabolic process | 1.93857933250456e-05 |
GO:0019222 | regulation of metabolic process | 2.07373405119266e-05 |
GO:0019724 | B cell mediated immunity | 2.19225889979397e-05 |
GO:0051239 | regulation of multicellular organismal process | 2.19225889979397e-05 |
GO:0002253 | activation of immune response | 2.42472631391152e-05 |
GO:0031325 | positive regulation of cellular metabolic process | 2.52028844850619e-05 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 2.6113260313665e-05 |
GO:0016044 | membrane organization and biogenesis | 2.96291024406554e-05 |
GO:0007275 | multicellular organismal development | 3.28162269880261e-05 |
GO:0044238 | primary metabolic process | 3.30120973243395e-05 |
GO:0006468 | protein amino acid phosphorylation | 3.43684116914692e-05 |
GO:0016310 | phosphorylation | 3.61440829059196e-05 |
GO:0044425 | membrane part | 3.8344408130855e-05 |
GO:0032635 | interleukin-6 production | 4.06180374127075e-05 |
GO:0044267 | cellular protein metabolic process | 5.12387297454074e-05 |
GO:0019992 | diacylglycerol binding | 5.21396798691282e-05 |
GO:0045859 | regulation of protein kinase activity | 5.78441588151654e-05 |
GO:0042035 | regulation of cytokine biosynthetic process | 5.82866992933787e-05 |
GO:0005096 | GTPase activator activity | 6.62777686415129e-05 |
GO:0005887 | integral to plasma membrane | 6.62777686415129e-05 |
GO:0043549 | regulation of kinase activity | 7.20219961431365e-05 |
GO:0004672 | protein kinase activity | 8.20552133082211e-05 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 8.62560274787019e-05 |
GO:0051338 | regulation of transferase activity | 8.99759037782292e-05 |
GO:0009889 | regulation of biosynthetic process | 9.19901748557854e-05 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 9.19901748557854e-05 |
GO:0031226 | intrinsic to plasma membrane | 9.2052245191411e-05 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 0.000106845638766849 |
GO:0042089 | cytokine biosynthetic process | 0.000123205026030262 |
GO:0043065 | positive regulation of apoptosis | 0.000131717537270196 |
GO:0044237 | cellular metabolic process | 0.000134442765175178 |
GO:0042107 | cytokine metabolic process | 0.000134442765175178 |
GO:0006793 | phosphorus metabolic process | 0.000134968609987214 |
GO:0006796 | phosphate metabolic process | 0.000134968609987214 |
GO:0009653 | anatomical structure morphogenesis | 0.000135832433009582 |
GO:0043068 | positive regulation of programmed cell death | 0.000137682657937617 |
GO:0010324 | membrane invagination | 0.000142524951185541 |
GO:0006897 | endocytosis | 0.000142524951185541 |
GO:0048513 | organ development | 0.000148748215308577 |
GO:0006916 | anti-apoptosis | 0.000158600669124775 |
GO:0002260 | lymphocyte homeostasis | 0.000161971248557648 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 0.000161971248557648 |
GO:0007049 | cell cycle | 0.000168455338725797 |
GO:0005764 | lysosome | 0.000169040310560079 |
GO:0000323 | lytic vacuole | 0.000175879890986852 |
GO:0005773 | vacuole | 0.000175879890986852 |
GO:0000902 | cell morphogenesis | 0.000175879890986852 |
GO:0032989 | cellular structure morphogenesis | 0.000175879890986852 |
GO:0043283 | biopolymer metabolic process | 0.000175879890986852 |
GO:0051090 | regulation of transcription factor activity | 0.000178779809974693 |
GO:0002449 | lymphocyte mediated immunity | 0.000178779809974693 |
GO:0006606 | protein import into nucleus | 0.000199194718536622 |
GO:0004871 | signal transducer activity | 0.000199194718536622 |
GO:0060089 | molecular transducer activity | 0.000199194718536622 |
GO:0032501 | multicellular organismal process | 0.000199194718536622 |
GO:0031323 | regulation of cellular metabolic process | 0.000199194718536622 |
GO:0002224 | toll-like receptor signaling pathway | 0.000199194718536622 |
GO:0002221 | pattern recognition receptor signaling pathway | 0.000199194718536622 |
GO:0001782 | B cell homeostasis | 0.000199194718536622 |
GO:0019899 | enzyme binding | 0.000209670156622561 |
GO:0044459 | plasma membrane part | 0.000220746902180751 |
GO:0033157 | regulation of intracellular protein transport | 0.000220746902180751 |
GO:0042306 | regulation of protein import into nucleus | 0.000220746902180751 |
GO:0051170 | nuclear import | 0.000220746902180751 |
GO:0042110 | T cell activation | 0.000220746902180751 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 0.000238168079240672 |
GO:0000267 | cell fraction | 0.000260244692140042 |
GO:0006417 | regulation of translation | 0.000287464837479106 |
GO:0002443 | leukocyte mediated immunity | 0.000287464837479106 |
GO:0046649 | lymphocyte activation | 0.000289090338790022 |
GO:0032386 | regulation of intracellular transport | 0.000406928694899644 |
GO:0001817 | regulation of cytokine production | 0.000406928694899644 |
GO:0051235 | maintenance of localization | 0.000406928694899644 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.000406928694899644 |
GO:0032640 | tumor necrosis factor production | 0.000425388916911271 |
GO:0042113 | B cell activation | 0.000436519458042769 |
GO:0002218 | activation of innate immune response | 0.000436519458042769 |
GO:0002758 | innate immune response-activating signal transduction | 0.000436519458042769 |
GO:0045185 | maintenance of protein localization | 0.000477595373883177 |
GO:0051247 | positive regulation of protein metabolic process | 0.000504554501252737 |
GO:0002252 | immune effector process | 0.000505616072729594 |
GO:0042127 | regulation of cell proliferation | 0.00053030865526599 |
GO:0009595 | detection of biotic stimulus | 0.000558035046025798 |
GO:0001776 | leukocyte homeostasis | 0.000558035046025798 |
GO:0002274 | myeloid leukocyte activation | 0.000559144771840552 |
GO:0031326 | regulation of cellular biosynthetic process | 0.000561209676122636 |
GO:0003712 | transcription cofactor activity | 0.000615689089228685 |
GO:0051223 | regulation of protein transport | 0.00066067970855473 |
GO:0010468 | regulation of gene expression | 0.00066067970855473 |
GO:0048534 | hemopoietic or lymphoid organ development | 0.00070671054586468 |
GO:0048872 | homeostasis of number of cells | 0.00072291227930451 |
GO:0016021 | integral to membrane | 0.000739522995320113 |
GO:0046822 | regulation of nucleocytoplasmic transport | 0.000767310905370015 |
GO:0005085 | guanyl-nucleotide exchange factor activity | 0.000767310905370015 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.000809856938063797 |
GO:0005057 | receptor signaling protein activity | 0.000840895505733988 |
GO:0043405 | regulation of MAP kinase activity | 0.000876264081011511 |
GO:0002455 | humoral immune response mediated by circulating immunoglobulin | 0.000885788773056769 |
GO:0031224 | intrinsic to membrane | 0.000918567875049023 |
GO:0015031 | protein transport | 0.000928566903816074 |
GO:0006917 | induction of apoptosis | 0.000951574335387679 |
GO:0012502 | induction of programmed cell death | 0.000990062321748732 |
GO:0017038 | protein import | 0.0010079216383447 |
GO:0016564 | transcription repressor activity | 0.00101970487408215 |
GO:0005794 | Golgi apparatus | 0.00101970487408215 |
GO:0002520 | immune system development | 0.00102457075488619 |
GO:0009967 | positive regulation of signal transduction | 0.00111553253922731 |
GO:0002757 | immune response-activating signal transduction | 0.00115990563039756 |
GO:0002764 | immune response-regulating signal transduction | 0.00134385879823729 |
GO:0043085 | positive regulation of catalytic activity | 0.0013860620179607 |
GO:0050871 | positive regulation of B cell activation | 0.0013999877127062 |
GO:0008289 | lipid binding | 0.0013999877127062 |
GO:0006350 | transcription | 0.0013999877127062 |
GO:0045727 | positive regulation of translation | 0.00143220607608904 |
GO:0007050 | cell cycle arrest | 0.00143220607608904 |
GO:0031324 | negative regulation of cellular metabolic process | 0.00149477289682098 |
GO:0008285 | negative regulation of cell proliferation | 0.00154075920568224 |
GO:0022402 | cell cycle process | 0.00155147037861787 |
GO:0030099 | myeloid cell differentiation | 0.00157379104853228 |
GO:0030097 | hemopoiesis | 0.0015904493236356 |
GO:0006928 | cell motility | 0.0015904493236356 |
GO:0051674 | localization of cell | 0.0015904493236356 |
GO:0009620 | response to fungus | 0.0016638172949723 |
GO:0019864 | IgG binding | 0.00182892753792743 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 0.00182892753792743 |
GO:0042533 | tumor necrosis factor biosynthetic process | 0.00182892753792743 |
GO:0016045 | detection of bacterium | 0.00182892753792743 |
GO:0009617 | response to bacterium | 0.00188565647270838 |
GO:0050663 | cytokine secretion | 0.00199921374353912 |
GO:0009306 | protein secretion | 0.00200656163015759 |
GO:0040008 | regulation of growth | 0.0021781854385877 |
GO:0004438 | phosphatidylinositol-3-phosphatase activity | 0.00222333512173573 |
GO:0033256 | I-kappaB/NF-kappaB complex | 0.00222333512173573 |
GO:0051896 | regulation of protein kinase B signaling cascade | 0.00222333512173573 |
GO:0002634 | regulation of germinal center formation | 0.00222333512173573 |
GO:0002266 | follicular dendritic cell activation | 0.00222333512173573 |
GO:0002268 | follicular dendritic cell differentiation | 0.00222333512173573 |
GO:0046696 | lipopolysaccharide receptor complex | 0.00222333512173573 |
GO:0002902 | regulation of B cell apoptosis | 0.00222333512173573 |
GO:0002903 | negative regulation of B cell apoptosis | 0.00222333512173573 |
GO:0033257 | Bcl3/NF-kappaB2 complex | 0.00222333512173573 |
GO:0016607 | nuclear speck | 0.00226952078661409 |
GO:0042990 | regulation of transcription factor import into nucleus | 0.00228400400131031 |
GO:0042991 | transcription factor import into nucleus | 0.00228400400131031 |
GO:0045860 | positive regulation of protein kinase activity | 0.00248361208409688 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.00248361208409688 |
GO:0042834 | peptidoglycan binding | 0.00248361208409688 |
GO:0008361 | regulation of cell size | 0.00249997916701087 |
GO:0009892 | negative regulation of metabolic process | 0.00251292657462567 |
GO:0003704 | specific RNA polymerase II transcription factor activity | 0.00251292657462567 |
GO:0019219 | regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00264895407238468 |
GO:0000060 | protein import into nucleus, translocation | 0.00266781112286974 |
GO:0016192 | vesicle-mediated transport | 0.00277155439822717 |
GO:0006935 | chemotaxis | 0.00277155439822717 |
GO:0042330 | taxis | 0.00277155439822717 |
GO:0033674 | positive regulation of kinase activity | 0.00277155439822717 |
GO:0042592 | homeostatic process | 0.00277155439822717 |
GO:0006909 | phagocytosis | 0.00308979829212634 |
GO:0001819 | positive regulation of cytokine production | 0.00310217522664878 |
GO:0051347 | positive regulation of transferase activity | 0.00318277979495032 |
GO:0045089 | positive regulation of innate immune response | 0.00329975516094788 |
GO:0002237 | response to molecule of bacterial origin | 0.00329975516094788 |
GO:0007626 | locomotory behavior | 0.00340222093393801 |
GO:0009719 | response to endogenous stimulus | 0.00346253883669758 |
GO:0006886 | intracellular protein transport | 0.00346253883669758 |
GO:0032507 | maintenance of cellular protein localization | 0.00356478571220302 |
GO:0005100 | Rho GTPase activator activity | 0.00356478571220302 |
GO:0016481 | negative regulation of transcription | 0.00372607278399943 |
GO:0043406 | positive regulation of MAP kinase activity | 0.00380319940307587 |
GO:0030155 | regulation of cell adhesion | 0.00380319940307587 |
GO:0007610 | behavior | 0.00405769825019489 |
GO:0050864 | regulation of B cell activation | 0.00406786771277168 |
GO:0051651 | maintenance of cellular localization | 0.00406786771277168 |
GO:0031347 | regulation of defense response | 0.00406786771277168 |
GO:0050727 | regulation of inflammatory response | 0.00406786771277168 |
GO:0006913 | nucleocytoplasmic transport | 0.00420493472130453 |
GO:0045088 | regulation of innate immune response | 0.00421898565002408 |
GO:0051101 | regulation of DNA binding | 0.00421898565002408 |
GO:0007266 | Rho protein signal transduction | 0.00431344681394228 |
GO:0007166 | cell surface receptor linked signal transduction | 0.00432388266846493 |
GO:0043285 | biopolymer catabolic process | 0.0043485995176637 |
GO:0044444 | cytoplasmic part | 0.00445199977952222 |
GO:0051169 | nuclear transport | 0.00449855735965538 |
GO:0006351 | transcription, DNA-dependent | 0.00449855735965538 |
GO:0032774 | RNA biosynthetic process | 0.00470757709268044 |
GO:0016301 | kinase activity | 0.00472793550449719 |
GO:0009891 | positive regulation of biosynthetic process | 0.00490357246070419 |
GO:0002440 | production of molecular mediator of immune response | 0.00525579452535207 |
GO:0008329 | pattern recognition receptor activity | 0.00530596839859969 |
GO:0042088 | T-helper 1 type immune response | 0.00530596839859969 |
GO:0042577 | lipid phosphatase activity | 0.00530596839859969 |
GO:0001783 | B cell apoptosis | 0.00533052027451271 |
GO:0001530 | lipopolysaccharide binding | 0.00533052027451271 |
GO:0046477 | glycosylceramide catabolic process | 0.00533052027451271 |
GO:0008339 | MP kinase activity | 0.00533052027451271 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 0.00533052027451271 |
GO:0006958 | complement activation, classical pathway | 0.0058706079836588 |
GO:0044428 | nuclear part | 0.00602396649121175 |
GO:0045449 | regulation of transcription | 0.00645900719813096 |
GO:0006020 | inositol metabolic process | 0.00661053066566868 |
GO:0030183 | B cell differentiation | 0.00663889512614563 |
GO:0016049 | cell growth | 0.00666454022393828 |
GO:0006959 | humoral immune response | 0.00669490893657115 |
GO:0031981 | nuclear lumen | 0.00701167784539665 |
GO:0051251 | positive regulation of lymphocyte activation | 0.00721865019066037 |
GO:0051091 | positive regulation of transcription factor activity | 0.00740554367868296 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.00740554367868296 |
GO:0045941 | positive regulation of transcription | 0.00740554367868296 |
GO:0045934 | negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00753510545326577 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.00833584181326916 |
GO:0002526 | acute inflammatory response | 0.00856200825930765 |
GO:0016604 | nuclear body | 0.00856200825930765 |
GO:0007169 | transmembrane receptor protein tyrosine kinase signaling pathway | 0.00895330076114232 |
GO:0044265 | cellular macromolecule catabolic process | 0.00919147312744725 |
GO:0005829 | cytosol | 0.00934445881406469 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 0.00934445881406469 |
GO:0006355 | regulation of transcription, DNA-dependent | 0.00934445881406469 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.00934445881406469 |
GO:0043632 | modification-dependent macromolecule catabolic process | 0.00934445881406469 |
GO:0019941 | modification-dependent protein catabolic process | 0.00934445881406469 |
GO:0001890 | placenta development | 0.00934445881406469 |
GO:0001565 | phorbol ester receptor activity | 0.00934445881406469 |
GO:0004697 | protein kinase C activity | 0.00934445881406469 |
GO:0032762 | mast cell cytokine production | 0.00934445881406469 |
GO:0019432 | triacylglycerol biosynthetic process | 0.00934445881406469 |
GO:0004681 | casein kinase I activity | 0.00934445881406469 |
GO:0042832 | defense response to protozoan | 0.00934445881406469 |
GO:0032763 | regulation of mast cell cytokine production | 0.00934445881406469 |
GO:0001975 | response to amphetamine | 0.00934445881406469 |
GO:0001892 | embryonic placenta development | 0.00934445881406469 |
GO:0014075 | response to amine stimulus | 0.00934445881406469 |
GO:0046514 | ceramide catabolic process | 0.00934445881406469 |
GO:0048536 | spleen development | 0.00934445881406469 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 0.00947450313935781 |
GO:0044257 | cellular protein catabolic process | 0.0100103033010618 |
GO:0000187 | activation of MAPK activity | 0.0108350148414493 |
GO:0045637 | regulation of myeloid cell differentiation | 0.0108857719829047 |
GO:0043433 | negative regulation of transcription factor activity | 0.0110384389471148 |
GO:0019865 | immunoglobulin binding | 0.0110384389471148 |
GO:0009887 | organ morphogenesis | 0.0110722832033106 |
GO:0007399 | nervous system development | 0.0116890920193093 |
GO:0048583 | regulation of response to stimulus | 0.0119662257172445 |
GO:0000165 | MAPKKK cascade | 0.0123229474835794 |
GO:0051046 | regulation of secretion | 0.0123459537611952 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0126556008439957 |
GO:0051048 | negative regulation of secretion | 0.012981943555186 |
GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway | 0.0131100094153854 |
GO:0060090 | molecular adaptor activity | 0.0131508350132592 |
GO:0006996 | organelle organization and biogenesis | 0.0140251682503365 |
GO:0008632 | apoptotic program | 0.0140251682503365 |
GO:0051457 | maintenance of protein localization in nucleus | 0.0143533537491886 |
GO:0001562 | response to protozoan | 0.0143533537491886 |
GO:0031401 | positive regulation of protein modification process | 0.0143533537491886 |
GO:0043491 | protein kinase B signaling cascade | 0.0143533537491886 |
GO:0045064 | T-helper 2 cell differentiation | 0.0143533537491886 |
GO:0045410 | positive regulation of interleukin-6 biosynthetic process | 0.0143533537491886 |
GO:0046521 | sphingoid catabolic process | 0.0143533537491886 |
GO:0002521 | leukocyte differentiation | 0.0145026035080263 |
GO:0010033 | response to organic substance | 0.0147339835509124 |
GO:0045638 | negative regulation of myeloid cell differentiation | 0.0147497066996684 |
GO:0002377 | immunoglobulin production | 0.0147497066996684 |
GO:0043233 | organelle lumen | 0.01490594205667 |
GO:0031974 | membrane-enclosed lumen | 0.01490594205667 |
GO:0051641 | cellular localization | 0.0162637245259618 |
GO:0030098 | lymphocyte differentiation | 0.0166453266974832 |
GO:0007259 | JAK-STAT cascade | 0.0166453266974832 |
GO:0006956 | complement activation | 0.0166453266974832 |
GO:0002541 | activation of plasma proteins during acute inflammatory response | 0.0166453266974832 |
GO:0005625 | soluble fraction | 0.0167623315410622 |
GO:0048503 | GPI anchor binding | 0.0173836267822387 |
GO:0035023 | regulation of Rho protein signal transduction | 0.017665184263463 |
GO:0001558 | regulation of cell growth | 0.0183002469971962 |
GO:0043167 | ion binding | 0.0184272063446712 |
GO:0031625 | ubiquitin protein ligase binding | 0.0193886096320649 |
GO:0042542 | response to hydrogen peroxide | 0.0193886096320649 |
GO:0001568 | blood vessel development | 0.0195140859974698 |
GO:0051020 | GTPase binding | 0.0199926444987049 |
GO:0016909 | SAP kinase activity | 0.0199926444987049 |
GO:0042119 | neutrophil activation | 0.0199926444987049 |
GO:0008354 | germ cell migration | 0.0199926444987049 |
GO:0045892 | negative regulation of transcription, DNA-dependent | 0.0205661016105646 |
GO:0001944 | vasculature development | 0.0206732510589604 |
GO:0042060 | wound healing | 0.020843442772185 |
GO:0040014 | regulation of multicellular organism growth | 0.0217780768316378 |
GO:0006801 | superoxide metabolic process | 0.0217780768316378 |
GO:0051174 | regulation of phosphorus metabolic process | 0.0217928288822071 |
GO:0019220 | regulation of phosphate metabolic process | 0.0217928288822071 |
GO:0051649 | establishment of cellular localization | 0.0220698353604131 |
GO:0001726 | ruffle | 0.0225295920369183 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 0.0229481913434765 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.0229481913434765 |
GO:0007265 | Ras protein signal transduction | 0.0237767981550979 |
GO:0031252 | leading edge | 0.0257714455900923 |
GO:0006800 | oxygen and reactive oxygen species metabolic process | 0.0262374214180816 |
GO:0046460 | neutral lipid biosynthetic process | 0.0263351924920615 |
GO:0046463 | acylglycerol biosynthetic process | 0.0263351924920615 |
GO:0001953 | negative regulation of cell-matrix adhesion | 0.0263351924920615 |
GO:0019377 | glycolipid catabolic process | 0.0263351924920615 |
GO:0031543 | peptidyl-proline dioxygenase activity | 0.0263351924920615 |
GO:0016070 | RNA metabolic process | 0.0263351924920615 |
GO:0009968 | negative regulation of signal transduction | 0.0265227587828139 |
GO:0051092 | activation of NF-kappaB transcription factor | 0.0271446694828396 |
GO:0006461 | protein complex assembly | 0.0285169091043676 |
GO:0009057 | macromolecule catabolic process | 0.0301509643917555 |
GO:0003714 | transcription corepressor activity | 0.0301509643917555 |
GO:0007167 | enzyme linked receptor protein signaling pathway | 0.0303015660173156 |
GO:0035264 | multicellular organism growth | 0.0303015660173156 |
GO:0006605 | protein targeting | 0.0304948554869333 |
GO:0051249 | regulation of lymphocyte activation | 0.0311060052260318 |
GO:0010467 | gene expression | 0.0311060052260318 |
GO:0030163 | protein catabolic process | 0.0313473053448635 |
GO:0001666 | response to hypoxia | 0.0316229277055235 |
GO:0051093 | negative regulation of developmental process | 0.0325448676104552 |
GO:0007264 | small GTPase mediated signal transduction | 0.0325448676104552 |
GO:0043506 | regulation of JNK activity | 0.0325448676104552 |
GO:0045937 | positive regulation of phosphate metabolic process | 0.0325448676104552 |
GO:0051241 | negative regulation of multicellular organismal process | 0.0325448676104552 |
GO:0045885 | positive regulation of survival gene product activity | 0.0325448676104552 |
GO:0045414 | regulation of interleukin-8 biosynthetic process | 0.0325448676104552 |
GO:0030279 | negative regulation of ossification | 0.0325448676104552 |
GO:0004680 | casein kinase activity | 0.0325448676104552 |
GO:0004908 | interleukin-1 receptor activity | 0.0325448676104552 |
GO:0046504 | glycerol ether biosynthetic process | 0.0325448676104552 |
GO:0006677 | glycosylceramide metabolic process | 0.0325448676104552 |
GO:0045017 | glycerolipid biosynthetic process | 0.0325448676104552 |
GO:0017022 | myosin binding | 0.0325448676104552 |
GO:0005070 | SH3/SH2 adaptor activity | 0.0328152215133495 |
GO:0000287 | magnesium ion binding | 0.0331592620783585 |
GO:0006974 | response to DNA damage stimulus | 0.0339857307778434 |
GO:0046872 | metal ion binding | 0.0340843194335913 |
GO:0048514 | blood vessel morphogenesis | 0.0345620099906766 |
GO:0009581 | detection of external stimulus | 0.0348449683767451 |
GO:0005624 | membrane fraction | 0.0349513423291501 |
GO:0016563 | transcription activator activity | 0.0351476911150477 |
GO:0050708 | regulation of protein secretion | 0.0355780392891336 |
GO:0019888 | protein phosphatase regulator activity | 0.036119034018545 |
GO:0050865 | regulation of cell activation | 0.036119034018545 |
GO:0003713 | transcription coactivator activity | 0.0365247810243425 |
GO:0044451 | nucleoplasm part | 0.0369271087799732 |
GO:0042995 | cell projection | 0.0380168597849864 |
GO:0050851 | antigen receptor-mediated signaling pathway | 0.0388206435412315 |
GO:0000302 | response to reactive oxygen species | 0.0388206435412315 |
GO:0019208 | phosphatase regulator activity | 0.0388206435412315 |
GO:0002700 | regulation of production of molecular mediator of immune response | 0.0388206435412315 |
GO:0042994 | cytoplasmic sequestering of transcription factor | 0.0388206435412315 |
GO:0042228 | interleukin-8 biosynthetic process | 0.0388206435412315 |
GO:0002367 | cytokine production during immune response | 0.0388206435412315 |
GO:0050777 | negative regulation of immune response | 0.0388206435412315 |
GO:0002718 | regulation of cytokine production during immune response | 0.0388206435412315 |
GO:0031348 | negative regulation of defense response | 0.0388206435412315 |
GO:0042116 | macrophage activation | 0.0388206435412315 |
GO:0050728 | negative regulation of inflammatory response | 0.0388206435412315 |
GO:0045191 | regulation of isotype switching | 0.0388206435412315 |
GO:0030890 | positive regulation of B cell proliferation | 0.0388206435412315 |
GO:0005089 | Rho guanyl-nucleotide exchange factor activity | 0.0390399174762732 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 0.0399937144638436 |
GO:0046651 | lymphocyte proliferation | 0.0402344846430698 |
GO:0032943 | mononuclear cell proliferation | 0.0402344846430698 |
GO:0051098 | regulation of binding | 0.0414296497374927 |
GO:0031267 | small GTPase binding | 0.0439801697447111 |
GO:0050793 | regulation of developmental process | 0.0442528033564641 |
GO:0006664 | glycolipid metabolic process | 0.0449153411911552 |
GO:0007163 | establishment and/or maintenance of cell polarity | 0.0449153411911552 |
GO:0008092 | cytoskeletal protein binding | 0.0449153411911552 |
GO:0051220 | cytoplasmic sequestering of protein | 0.0449153411911552 |
GO:0002683 | negative regulation of immune system process | 0.0449153411911552 |
GO:0001818 | negative regulation of cytokine production | 0.0449153411911552 |
GO:0031399 | regulation of protein modification process | 0.0449153411911552 |
GO:0002263 | cell activation during immune response | 0.0449153411911552 |
GO:0002294 | CD4-positive, alpha-beta T cell differentiation during immune response | 0.0449153411911552 |
GO:0002285 | lymphocyte activation during immune response | 0.0449153411911552 |
GO:0022408 | negative regulation of cell-cell adhesion | 0.0449153411911552 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 0.0449153411911552 |
GO:0002292 | T cell differentiation during immune response | 0.0449153411911552 |
GO:0030888 | regulation of B cell proliferation | 0.0449153411911552 |
GO:0042092 | T-helper 2 type immune response | 0.0449153411911552 |
GO:0042093 | T-helper cell differentiation | 0.0449153411911552 |
GO:0002366 | leukocyte activation during immune response | 0.0449153411911552 |
GO:0017053 | transcriptional repressor complex | 0.0449153411911552 |
GO:0050702 | interleukin-1 beta secretion | 0.0449153411911552 |
GO:0019966 | interleukin-1 binding | 0.0449153411911552 |
GO:0002286 | T cell activation during immune response | 0.0449153411911552 |
GO:0002293 | alpha-beta T cell differentiation during immune response | 0.0449153411911552 |
GO:0031575 | G1/S transition checkpoint | 0.0449153411911552 |
GO:0043086 | negative regulation of catalytic activity | 0.0458411256007982 |
GO:0050671 | positive regulation of lymphocyte proliferation | 0.0473015148732841 |
GO:0032946 | positive regulation of mononuclear cell proliferation | 0.0473015148732841 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
hematopoietic system | 1.46e-81 | 98 |
blood island | 1.46e-81 | 98 |
hemolymphoid system | 8.31e-73 | 108 |
bone marrow | 5.43e-65 | 76 |
bone element | 2.01e-59 | 82 |
immune system | 1.63e-53 | 93 |
skeletal element | 3.82e-53 | 90 |
skeletal system | 1.07e-46 | 100 |
lateral plate mesoderm | 1.92e-32 | 203 |
musculoskeletal system | 2.26e-23 | 167 |
blood | 1.80e-20 | 15 |
haemolymphatic fluid | 1.80e-20 | 15 |
organism substance | 1.80e-20 | 15 |
mesoderm | 6.21e-17 | 315 |
mesoderm-derived structure | 6.21e-17 | 315 |
presumptive mesoderm | 6.21e-17 | 315 |
connective tissue | 2.49e-14 | 371 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 3.00624 |
MA0004.1 | 0.81623 |
MA0006.1 | 0.0573594 |
MA0007.1 | 0.200994 |
MA0009.1 | 1.21969 |
MA0014.1 | 0.0932167 |
MA0017.1 | 1.9955 |
MA0019.1 | 1.13235 |
MA0024.1 | 0.014489 |
MA0025.1 | 4.89923 |
MA0027.1 | 0.286244 |
MA0028.1 | 5.85577 |
MA0029.1 | 0.0307475 |
MA0030.1 | 5.80198 |
MA0031.1 | 5.46364 |
MA0038.1 | 0.56218 |
MA0040.1 | 0.119868 |
MA0041.1 | 1.31974e-05 |
MA0042.1 | 0.0654446 |
MA0043.1 | 19.3312 |
MA0046.1 | 9.32918e-06 |
MA0048.1 | 0.182251 |
MA0050.1 | 0.429027 |
MA0051.1 | 0.386939 |
MA0052.1 | 0.000130269 |
MA0055.1 | 1.04079 |
MA0056.1 | 0 |
MA0057.1 | 4.61562 |
MA0058.1 | 1.4129 |
MA0059.1 | 2.65455 |
MA0060.1 | 9.64327e-16 |
MA0061.1 | 70.3086 |
MA0063.1 | 0 |
MA0066.1 | 5.89145 |
MA0067.1 | 3.81898 |
MA0068.1 | 0.270068 |
MA0069.1 | 1.1245 |
MA0070.1 | 6.86408e-05 |
MA0071.1 | 1.39827 |
MA0072.1 | 0.0597634 |
MA0073.1 | 0.190376 |
MA0074.1 | 1.20535 |
MA0076.1 | 8.51514 |
MA0077.1 | 0.0170488 |
MA0078.1 | 1.01211 |
MA0081.1 | 26.5265 |
MA0083.1 | 1.36735 |
MA0084.1 | 0.0655347 |
MA0087.1 | 0.0218834 |
MA0088.1 | 0.519552 |
MA0089.1 | 0 |
MA0090.1 | 0.0261158 |
MA0091.1 | 0.179124 |
MA0092.1 | 0.0621574 |
MA0093.1 | 1.30796 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.881144 |
MA0101.1 | 49.0652 |
MA0103.1 | 0.110103 |
MA0105.1 | 37.335 |
MA0106.1 | 0.0688737 |
MA0107.1 | 69.5108 |
MA0108.2 | 0.000187498 |
MA0109.1 | 0 |
MA0111.1 | 0.609879 |
MA0113.1 | 1.00411 |
MA0114.1 | 1.12064 |
MA0115.1 | 0.385337 |
MA0116.1 | 3.32342 |
MA0117.1 | 2.60158 |
MA0119.1 | 0.375057 |
MA0122.1 | 0.934205 |
MA0124.1 | 0.00667389 |
MA0125.1 | 0.00471843 |
MA0130.1 | 0 |
MA0131.1 | 0.330199 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.00296207 |
MA0136.1 | 40.6715 |
MA0139.1 | 0.410921 |
MA0140.1 | 2.05459e-05 |
MA0141.1 | 6.50755 |
MA0142.1 | 0.0049029 |
MA0143.1 | 0.0796893 |
MA0144.1 | 8.62831 |
MA0145.1 | 1.7831 |
MA0146.1 | 4.6581 |
MA0147.1 | 0.444758 |
MA0148.1 | 0.765552 |
MA0149.1 | 0.00792609 |
MA0062.2 | 38.9521 |
MA0035.2 | 0.00250007 |
MA0039.2 | 6.4619 |
MA0138.2 | 0.00431808 |
MA0002.2 | 31.0719 |
MA0137.2 | 6.03159 |
MA0104.2 | 0.677711 |
MA0047.2 | 0.443672 |
MA0112.2 | 3.25054 |
MA0065.2 | 4.93337 |
MA0150.1 | 34.4168 |
MA0151.1 | 0 |
MA0152.1 | 1.20235e-05 |
MA0153.1 | 3.02474e-05 |
MA0154.1 | 8.94257 |
MA0155.1 | 9.17214 |
MA0156.1 | 51.2671 |
MA0157.1 | 2.18887 |
MA0158.1 | 0 |
MA0159.1 | 6.774 |
MA0160.1 | 5.65509 |
MA0161.1 | 0 |
MA0162.1 | 0.000271406 |
MA0163.1 | 3.10941 |
MA0164.1 | 0.922326 |
MA0080.2 | 120.336 |
MA0018.2 | 11.4506 |
MA0099.2 | 10.6584 |
MA0079.2 | 12.8702 |
MA0102.2 | 11.7688 |
MA0258.1 | 1.88993 |
MA0259.1 | 0.150615 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
BATF#10538 | 603 | 3.11379149475495 | 1.57450732966158e-135 | 3.91523740482203e-132 |
BCL11A#53335 | 600 | 3.6085802548578 | 1.7539085174532e-164 | 5.23361290440843e-161 |
BCL3#602 | 346 | 2.53408894850402 | 6.05193242653807e-55 | 4.93795133355632e-52 |
BCLAF1#9774 | 280 | 1.28529602095275 | 1.50620806988876e-05 | 0.000356785812227517 |
BHLHE40#8553 | 157 | 1.49350746806772 | 7.36771583678697e-07 | 3.27019496080831e-05 |
BRCA1#672 | 340 | 1.45487352526947 | 6.13280611088516e-12 | 7.8879819878662e-10 |
BRF2#55290 | 10 | 2.27809112019366 | 0.0134254500753273 | 0.0474337138165462 |
CCNT2#905 | 1044 | 1.40237321313313 | 3.35039193431519e-31 | 1.41093380333848e-28 |
CEBPB#1051 | 1337 | 2.25936493019457 | 2.22371263468074e-189 | 8.2943687090508e-186 |
CHD2#1106 | 607 | 1.33110490996585 | 2.977003912083e-13 | 4.43531114941564e-11 |
CTCF#10664 | 998 | 1.13409706600146 | 5.86039447614214e-06 | 0.000175978648273091 |
E2F1#1869 | 1041 | 1.08301720854131 | 0.00199368428172762 | 0.0115940972603904 |
E2F6#1876 | 1159 | 1.23275036952242 | 1.94068477717669e-15 | 3.555845218308e-13 |
EBF1#1879 | 1437 | 2.71329083284284 | 1.36179324670294e-287 | 1.09403326840314e-283 |
EGR1#1958 | 1441 | 1.52384271266089 | 2.17716608576368e-67 | 2.22922596893209e-64 |
ELF1#1997 | 1913 | 1.72689026822108 | 3.12712755085306e-153 | 8.59458090219849e-150 |
ELK4#2005 | 427 | 1.46971296759929 | 2.04680239803888e-15 | 3.7371677560976e-13 |
EP300#2033 | 1266 | 1.81806449552651 | 3.81367172443084e-105 | 6.8671734694454e-102 |
ESR1#2099 | 211 | 1.37633565730095 | 2.99094460745262e-06 | 0.000101419241512255 |
ETS1#2113 | 629 | 1.29730562223135 | 9.16878026526434e-12 | 1.14955371203354e-09 |
FOS#2353 | 948 | 1.80836583269703 | 5.69591666213972e-74 | 6.60973155863566e-71 |
FOSL1#8061 | 272 | 2.29003470062613 | 1.03497121068419e-35 | 5.19669991695415e-33 |
FOSL2#2355 | 528 | 1.8950913545068 | 6.61121943980273e-45 | 4.2886282426929e-42 |
FOXA1#3169 | 658 | 1.54580754613009 | 3.08137116510974e-29 | 1.18751041739076e-26 |
FOXA2#3170 | 338 | 1.76491345100718 | 1.62438904422278e-23 | 4.9031666875602e-21 |
GABPB1#2553 | 1005 | 1.50583469479819 | 1.20523810925413e-41 | 7.19279216527957e-39 |
GATA1#2623 | 519 | 1.49200761641561 | 7.19198994091569e-20 | 1.80125716412301e-17 |
GATA2#2624 | 610 | 1.64816797911129 | 3.33704384871586e-34 | 1.58417055689107e-31 |
GATA3#2625 | 232 | 1.33959546213097 | 6.13019466523317e-06 | 0.000182039067569601 |
GTF2F1#2962 | 497 | 1.34229625943366 | 1.76061918351437e-11 | 2.13314741191481e-09 |
HDAC2#3066 | 575 | 1.63535756541448 | 2.57796644930424e-31 | 1.09447251219059e-28 |
HEY1#23462 | 1385 | 1.18625265946606 | 1.65937826835444e-13 | 2.53739102443146e-11 |
HMGN3#9324 | 839 | 1.45469610767249 | 3.09089087428406e-29 | 1.18679982360056e-26 |
HNF4A#3172 | 321 | 1.57419232701042 | 2.00083193867761e-15 | 3.65963024244397e-13 |
HNF4G#3174 | 248 | 1.51173389581488 | 1.64350318369824e-10 | 1.72681920525413e-08 |
HSF1#3297 | 48 | 1.67181513673945 | 0.000500088293566223 | 0.00441158216840635 |
IRF1#3659 | 795 | 1.28716243037594 | 4.1218181619148e-14 | 6.7579052906157e-12 |
IRF4#3662 | 585 | 2.71782699210204 | 2.33611858567745e-106 | 4.43603434490123e-103 |
JUN#3725 | 835 | 2.21501216357872 | 3.78173320072402e-106 | 6.92913041667397e-103 |
JUNB#3726 | 317 | 2.0571487286757 | 6.0464863066957e-33 | 2.73371854279218e-30 |
JUND#3727 | 1201 | 1.78091825189466 | 5.87643584149747e-93 | 8.6440715894388e-90 |
MAFF#23764 | 159 | 1.8982704434813 | 3.75546300092429e-14 | 6.17664252525247e-12 |
MAFK#7975 | 373 | 2.14300900157103 | 1.74674627873169e-42 | 1.06683295090327e-39 |
MAX#4149 | 1375 | 1.88091240722595 | 1.04639285824948e-127 | 2.32519624941952e-124 |
MEF2A#4205 | 581 | 2.30863200307466 | 2.31509690146235e-78 | 2.87840958680745e-75 |
MEF2C#4208 | 251 | 2.1982510022575 | 2.32016721266587e-30 | 9.46546654389106e-28 |
MXI1#4601 | 575 | 1.21431072430286 | 7.08980540470073e-07 | 3.17518090335137e-05 |
MYC#4609 | 1327 | 1.46914734865925 | 6.62704644947947e-52 | 5.1268304010162e-49 |
NFE2#4778 | 126 | 2.06227196143847 | 6.52615168015856e-14 | 1.04537539160135e-11 |
NFKB1#4790 | 1820 | 2.11750592156726 | 1.02153647160843e-242 | 6.66801547239458e-239 |
NR3C1#2908 | 551 | 1.74902180527376 | 2.57373470365063e-37 | 1.37141978936004e-34 |
NR4A1#3164 | 7 | 4.09376374434801 | 0.00160289278772352 | 0.0100961654820009 |
PAX5#5079 | 1394 | 1.97103547815601 | 1.45015979591561e-146 | 3.88341638270847e-143 |
PBX3#5090 | 347 | 1.61211276283659 | 4.6379070491652e-18 | 1.02622536929611e-15 |
POLR2A#5430 | 3172 | 1.44407917660424 | 7.64891108489399e-185 | 2.66281541598415e-181 |
POU2F2#5452 | 985 | 1.90153321960492 | 7.85761097650533e-89 | 1.09418804370032e-85 |
PPARGC1A#10891 | 33 | 2.44894795420818 | 3.31905107199618e-06 | 0.000110924279970627 |
PRDM1#639 | 62 | 1.73277915162234 | 3.15908825919016e-05 | 0.000634484651349156 |
RAD21#5885 | 599 | 1.31495978447707 | 3.48076630385273e-12 | 4.60744932836597e-10 |
RDBP#7936 | 47 | 1.53084693396887 | 0.00321966187353143 | 0.0166852709973577 |
REST#5978 | 599 | 1.22543294487189 | 1.24592755643261e-07 | 7.14571268897668e-06 |
RFX5#5993 | 589 | 1.50439251160015 | 2.32187696368891e-23 | 6.94826671090849e-21 |
RXRA#6256 | 414 | 1.76190194945965 | 1.47506845600046e-28 | 5.46293171901532e-26 |
SIN3A#25942 | 1180 | 1.35308119093531 | 1.30735431580436e-29 | 5.17192338592012e-27 |
SIRT6#51548 | 66 | 2.14969994982863 | 1.13429751671312e-08 | 8.5226545574102e-07 |
SMARCA4#6597 | 47 | 1.56200921252295 | 0.00220645797214348 | 0.0127083364116634 |
SMARCB1#6598 | 419 | 1.62134575202564 | 4.16785690146597e-22 | 1.16698875853138e-19 |
SMARCC1#6599 | 263 | 2.43448452428728 | 7.02829969366191e-39 | 3.90440740269338e-36 |
SMARCC2#6601 | 89 | 1.77651649862071 | 2.56542729496186e-07 | 1.3316633263346e-05 |
SMC3#9126 | 516 | 1.64578871061805 | 1.17837180247296e-28 | 4.42690549203143e-26 |
SP1#6667 | 1363 | 1.64657490320247 | 3.09344823308663e-84 | 4.03845800019169e-81 |
SPI1#6688 | 1702 | 2.96030498441927 | 0 | 0 |
SRF#6722 | 542 | 1.58534462965761 | 2.28210834159033e-26 | 7.71330463065867e-24 |
STAT1#6772 | 383 | 1.68128535328117 | 7.24824770574766e-23 | 2.09115950867564e-20 |
STAT2#6773 | 134 | 1.85400579584122 | 1.81710135662243e-11 | 2.19394507033861e-09 |
STAT3#6774 | 1127 | 2.51334260160967 | 4.29422400436023e-190 | 1.66105355848659e-186 |
TAF1#6872 | 1904 | 1.34940854951432 | 3.95245633301336e-54 | 3.19992703072544e-51 |
TAL1#6886 | 270 | 1.70967277992556 | 2.96363250111955e-17 | 6.14124632508778e-15 |
TBP#6908 | 1834 | 1.44121633244324 | 1.57269067473311e-72 | 1.78532871063534e-69 |
TCF12#6938 | 936 | 2.11020969863186 | 2.56674074467777e-108 | 4.96421919691484e-105 |
TCF7L2#6934 | 557 | 1.27178044215974 | 2.99607175048545e-09 | 2.51330712890723e-07 |
TFAP2A#7020 | 443 | 1.55135786034745 | 7.06405102223501e-20 | 1.77346736709424e-17 |
TFAP2C#7022 | 677 | 1.55137752149149 | 1.49422482961671e-30 | 6.11981752864077e-28 |
TRIM28#10155 | 291 | 1.146882083564 | 0.0090742872402377 | 0.0343472559105242 |
USF1#7391 | 1044 | 1.40797228013676 | 7.65550924098737e-32 | 3.30385838685735e-29 |
USF2#7392 | 612 | 1.68565291491681 | 5.1376258072146e-37 | 2.70994192767518e-34 |
WRNIP1#56897 | 99 | 2.30489219219594 | 5.18797406898318e-14 | 8.41345999674742e-12 |
YY1#7528 | 1266 | 1.31811366744011 | 1.65106811120892e-27 | 5.9256323871666e-25 |
ZBTB7A#51341 | 980 | 1.52742656809802 | 5.97324943734373e-43 | 3.69136211826475e-40 |
ZEB1#6935 | 412 | 1.47509730575113 | 3.91279852011059e-15 | 6.94980892248011e-13 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data